The Gist Healthcare Podcast

A Texas court overturns a HHS change to how Medicare pays hospitals that serve large numbers of low-income patients. Medical-cost fiduciary litigation is on the rise. And the FDA authorizes the first over-the-counter, at-home syphilis test. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Biden’s nursing home staffing mandate gets hit with another lawsuit. This one from the Texas attorney general. Eli Lilly takes action to halt the sales of copycats of its GLP-1 drugs. And Kentucky is the first state to decriminalize medical errors. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

CMS releases results from its first Medicare prescription drug price negotiations under a new federal program. The WHO declares mpox a global public health emergency. And Elevance Health closes a deal with a private equity firm to create a primary care company. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Steward Health Care signs a definitive agreement to sell its physician group. President Biden announces $150 million dollars in federal awards as part of his “cancer moonshot.” And with no federal AI guidelines on the books, states create their own. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The FDA approves the first nasal spray formulation to treat anaphylaxis. A report finds that U.S. not-for-profit healthcare providers’ days cash on hand hit a 10-year low. And all eligible hospitals in North Carolina opt into the state’s new medical debt relief program. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A medical journal retracts three papers on MDMA-assisted psychotherapy following the FDA’s rejection of the treatment. CMS outlines updates for its ACO REACH model for 2025. And the DOJ finalizes a rule to improve access to medical care for people with disabilities. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A federal judge dismisses a lawsuit over the Medicare drug price negotiation program. Provisional data show that COVID has dropped to the 10th leading cause of death in the U.S. And a recent poll finds that fewer Americans view childhood vaccinations as “important.” That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

CMS finalizes a policy that creates a faster pathway to reimbursement for “breakthrough” medical devices. The FDA approves Purdue Pharma’s opioid overdose-reversal device. And a recent report finds that untreated vision loss and high cholesterol could be risk factors for dementia. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Providers receive a win in the latest appeals court ruling on the No Surprises Act. About 700 rural hospitals are at risk of closing, according to a new report. And a recent survey finds that less than half of Americans trust doctors. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Tenet Healthcare plans to sell its majority stake in five Alabama hospitals. The FDA now lists Eli Lilly’s blockbuster GLP-1 drugs as “available.” And a new study finds that less than half of patients challenge insurance claim denials. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.